A citation-based method for searching scientific literature

Franziska Lang, Barbara Schrörs, Martin Löwer, Özlem Türeci, Ugur Sahin. Nat Rev Drug Discov 2022
Times Cited: 22







List of co-cited articles
226 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer.
Ugur Sahin, Evelyna Derhovanessian, Matthias Miller, Björn-Philipp Kloke, Petra Simon, Martin Löwer, Valesca Bukur, Arbel D Tadmor, Ulrich Luxemburger, Barbara Schrörs,[...]. Nature 2017
40

An immunogenic personal neoantigen vaccine for patients with melanoma.
Patrick A Ott, Zhuting Hu, Derin B Keskin, Sachet A Shukla, Jing Sun, David J Bozym, Wandi Zhang, Adrienne Luoma, Anita Giobbie-Hurder, Lauren Peter,[...]. Nature 2017
36

Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells.
Beatriz M Carreno, Vincent Magrini, Michelle Becker-Hapak, Saghar Kaabinejadian, Jasreet Hundal, Allegra A Petti, Amy Ly, Wen-Rong Lie, William H Hildebrand, Elaine R Mardis,[...]. Science 2015
785
31

An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma.
Ugur Sahin, Petra Oehm, Evelyna Derhovanessian, Robert A Jabulowsky, Mathias Vormehr, Maike Gold, Daniel Maurus, Doreen Schwarck-Kokarakis, Andreas N Kuhn, Tana Omokoko,[...]. Nature 2020
232
31

Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial.
Derin B Keskin, Annabelle J Anandappa, Jing Sun, Itay Tirosh, Nathan D Mathewson, Shuqiang Li, Giacomo Oliveira, Anita Giobbie-Hurder, Kristen Felt, Evisa Gjini,[...]. Nature 2019
630
31

Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma.
Zhuting Hu, Donna E Leet, Rosa L Allesøe, Giacomo Oliveira, Shuqiang Li, Adrienne M Luoma, Jinyan Liu, Juliet Forman, Teddy Huang, J Bryan Iorgulescu,[...]. Nat Med 2021
118
31

mRNA vaccine for cancer immunotherapy.
Lei Miao, Yu Zhang, Leaf Huang. Mol Cancer 2021
141
27

Turning the corner on therapeutic cancer vaccines.
Robert E Hollingsworth, Kathrin Jansen. NPJ Vaccines 2019
297
27

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.
Naiyer A Rizvi, Matthew D Hellmann, Alexandra Snyder, Pia Kvistborg, Vladimir Makarov, Jonathan J Havel, William Lee, Jianda Yuan, Phillip Wong, Teresa S Ho,[...]. Science 2015
22

mRNA vaccines - a new era in vaccinology.
Norbert Pardi, Michael J Hogan, Frederick W Porter, Drew Weissman. Nat Rev Drug Discov 2018
22

mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer.
Gal Cafri, Jared J Gartner, Tal Zaks, Kristen Hopson, Noam Levin, Biman C Paria, Maria R Parkhurst, Rami Yossef, Frank J Lowery, Mohammad S Jafferji,[...]. J Clin Invest 2020
90
22


Actively personalized vaccination trial for newly diagnosed glioblastoma.
Norbert Hilf, Sabrina Kuttruff-Coqui, Katrin Frenzel, Valesca Bukur, Stefan Stevanović, Cécile Gouttefangeas, Michael Platten, Ghazaleh Tabatabai, Valerie Dutoit, Sjoerd H van der Burg,[...]. Nature 2019
425
22

Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis.
Samra Turajlic, Kevin Litchfield, Hang Xu, Rachel Rosenthal, Nicholas McGranahan, James L Reading, Yien Ning S Wong, Andrew Rowan, Nnennaya Kanu, Maise Al Bakir,[...]. Lancet Oncol 2017
506
22

MHC-II neoantigens shape tumour immunity and response to immunotherapy.
Elise Alspach, Danielle M Lussier, Alexander P Miceli, Ilya Kizhvatov, Michel DuPage, Adrienne M Luoma, Wei Meng, Cheryl F Lichti, Ekaterina Esaulova, Anthony N Vomund,[...]. Nature 2019
332
22

A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer.
Patrick A Ott, Siwen Hu-Lieskovan, Bartosz Chmielowski, Ramaswamy Govindan, Aung Naing, Nina Bhardwaj, Kim Margolin, Mark M Awad, Matthew D Hellmann, Jessica J Lin,[...]. Cell 2020
173
22

Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction.
Jennifer G Abelin, Derin B Keskin, Siranush Sarkizova, Christina R Hartigan, Wandi Zhang, John Sidney, Jonathan Stevens, William Lane, Guang Lan Zhang, Thomas M Eisenhaure,[...]. Immunity 2017
325
18

Neoantigen vaccine: an emerging tumor immunotherapy.
Miao Peng, Yongzhen Mo, Yian Wang, Pan Wu, Yijie Zhang, Fang Xiong, Can Guo, Xu Wu, Yong Li, Xiaoling Li,[...]. Mol Cancer 2019
205
18

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer.
Alexandros Papachristofilou, Madeleine M Hipp, Ute Klinkhardt, Martin Früh, Martin Sebastian, Christian Weiss, Miklos Pless, Richard Cathomas, Wolfgang Hilbe, Georg Pall,[...]. J Immunother Cancer 2019
64
18

Towards personalized, tumour-specific, therapeutic vaccines for cancer.
Zhuting Hu, Patrick A Ott, Catherine J Wu. Nat Rev Immunol 2018
441
18

mRNA therapeutics in cancer immunotherapy.
Jan D Beck, Daniel Reidenbach, Nadja Salomon, Ugur Sahin, Özlem Türeci, Mathias Vormehr, Lena M Kranz. Mol Cancer 2021
54
18

PD-1 blockade induces responses by inhibiting adaptive immune resistance.
Paul C Tumeh, Christina L Harview, Jennifer H Yearley, I Peter Shintaku, Emma J M Taylor, Lidia Robert, Bartosz Chmielowski, Marko Spasic, Gina Henry, Voicu Ciobanu,[...]. Nature 2014
18

Signatures of mutational processes in human cancer.
Ludmil B Alexandrov, Serena Nik-Zainal, David C Wedge, Samuel A J R Aparicio, Sam Behjati, Andrew V Biankin, Graham R Bignell, Niccolò Bolli, Ake Borg, Anne-Lise Børresen-Dale,[...]. Nature 2013
18

Immunogenic neoantigens derived from gene fusions stimulate T cell responses.
Wei Yang, Ken-Wing Lee, Raghvendra M Srivastava, Fengshen Kuo, Chirag Krishna, Diego Chowell, Vladimir Makarov, Douglas Hoen, Martin G Dalin, Leonard Wexler,[...]. Nat Med 2019
161
18

Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification.
Brendan Bulik-Sullivan, Jennifer Busby, Christine D Palmer, Matthew J Davis, Tyler Murphy, Andrew Clark, Michele Busby, Fujiko Duke, Aaron Yang, Lauren Young,[...]. Nat Biotechnol 2018
115
18

Cancer Neoantigens.
Ton N Schumacher, Wouter Scheper, Pia Kvistborg. Annu Rev Immunol 2019
239
18

Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy.
Lena M Kranz, Mustafa Diken, Heinrich Haas, Sebastian Kreiter, Carmen Loquai, Kerstin C Reuter, Martin Meng, Daniel Fritz, Fulvia Vascotto, Hossam Hefesha,[...]. Nature 2016
797
18

Shared Immunogenic Poly-Epitope Frameshift Mutations in Microsatellite Unstable Tumors.
Vladimir Roudko, Cansu Cimen Bozkus, Theofano Orfanelli, Christopher B McClain, Caitlin Carr, Timothy O'Donnell, Lauren Chakraborty, Robert Samstein, Kuan-Lin Huang, Stephanie V Blank,[...]. Cell 2020
55
18

Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.
Vinod P Balachandran, Marta Łuksza, Julia N Zhao, Vladimir Makarov, John Alec Moral, Romain Remark, Brian Herbst, Gokce Askan, Umesh Bhanot, Yasin Senbabaoglu,[...]. Nature 2017
587
18

NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data.
Vanessa Jurtz, Sinu Paul, Massimo Andreatta, Paolo Marcatili, Bjoern Peters, Morten Nielsen. J Immunol 2017
652
18

A large peptidome dataset improves HLA class I epitope prediction across most of the human population.
Siranush Sarkizova, Susan Klaeger, Phuong M Le, Letitia W Li, Giacomo Oliveira, Hasmik Keshishian, Christina R Hartigan, Wandi Zhang, David A Braun, Keith L Ligon,[...]. Nat Biotechnol 2020
152
13

Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction.
Daniel K Wells, Marit M van Buuren, Kristen K Dang, Vanessa M Hubbard-Lucey, Kathleen C F Sheehan, Katie M Campbell, Andrew Lamb, Jeffrey P Ward, John Sidney, Ana B Blazquez,[...]. Cell 2020
123
13

T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer.
Eric Tran, Paul F Robbins, Yong-Chen Lu, Todd D Prickett, Jared J Gartner, Li Jia, Anna Pasetto, Zhili Zheng, Satyajit Ray, Eric M Groh,[...]. N Engl J Med 2016
686
13

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma.
T Wölfel, M Hauer, J Schneider, M Serrano, C Wölfel, E Klehmann-Hieb, E De Plaen, T Hankeln, K H Meyer zum Büschenfelde, D Beach. Science 1995
917
13

Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing.
Mahesh Yadav, Suchit Jhunjhunwala, Qui T Phung, Patrick Lupardus, Joshua Tanguay, Stephanie Bumbaca, Christian Franci, Tommy K Cheung, Jens Fritsche, Toni Weinschenk,[...]. Nature 2014
746
13

A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients.
S Wilgenhof, A M T Van Nuffel, D Benteyn, J Corthals, C Aerts, C Heirman, I Van Riet, A Bonehill, K Thielemans, B Neyns. Ann Oncol 2013
118
13

Personalized vaccines for cancer immunotherapy.
Ugur Sahin, Özlem Türeci. Science 2018
409
13


Recent advances in mRNA vaccine technology.
Norbert Pardi, Michael J Hogan, Drew Weissman. Curr Opin Immunol 2020
149
13

Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response.
Sergio Linares-Fernández, Céline Lacroix, Jean-Yves Exposito, Bernard Verrier. Trends Mol Med 2020
97
13

Formulation and Delivery Technologies for mRNA Vaccines.
Chunxi Zeng, Chengxiang Zhang, Patrick G Walker, Yizhou Dong. Curr Top Microbiol Immunol 2020
69
13

Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion.
Suchit Jhunjhunwala, Christian Hammer, Lélia Delamarre. Nat Rev Cancer 2021
168
13

TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma.
Brenda De Keersmaecker, Sofie Claerhout, Javier Carrasco, Isabelle Bar, Jurgen Corthals, Sofie Wilgenhof, Bart Neyns, Kris Thielemans. J Immunother Cancer 2020
46
13

Oncology meets immunology: the cancer-immunity cycle.
Daniel S Chen, Ira Mellman. Immunity 2013
13

Self-amplifying RNA vaccines for infectious diseases.
Kristie Bloom, Fiona van den Berg, Patrick Arbuthnot. Gene Ther 2021
84
13

Dendritic Cell-Based Immunotherapy: State of the Art and Beyond.
Kalijn F Bol, Gerty Schreibelt, Winald R Gerritsen, I Jolanda M de Vries, Carl G Figdor. Clin Cancer Res 2016
214
13


Therapeutic cancer vaccines.
Mansi Saxena, Sjoerd H van der Burg, Cornelis J M Melief, Nina Bhardwaj. Nat Rev Cancer 2021
186
13

The Changing Landscape of Therapeutic Cancer Vaccines-Novel Platforms and Neoantigen Identification.
Jessica Jou, Kevin J Harrington, Mai-Britt Zocca, Eva Ehrnrooth, Ezra E W Cohen. Clin Cancer Res 2021
51
13

Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade.
Nicholas McGranahan, Andrew J S Furness, Rachel Rosenthal, Sofie Ramskov, Rikke Lyngaa, Sunil Kumar Saini, Mariam Jamal-Hanjani, Gareth A Wilson, Nicolai J Birkbak, Crispin T Hiley,[...]. Science 2016
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.